[The allergic pregnant woman]

Area of Science:

• Obstetrics and Gynecology
• Pharmacology
• Neonatal Health

Background:

• Drug administration during pregnancy necessitates careful monitoring due to potential risks to both mother and fetus.
• The prevention of fetal dietary sensitization and the role of environmental factors remain areas of ongoing discussion and research.
• Untreated or undertreated asthma in pregnant individuals presents significant risks, potentially outweighing the risks associated with necessary medication.

Purpose of the Study:

• To review the safety and efficacy of asthma medications during pregnancy.
• To provide guidance on managing asthma in pregnant women, balancing maternal and fetal well-being.
• To identify appropriate antihistamine options for different stages of pregnancy.

Main Methods:

• Literature review of studies on asthma management in pregnancy.
• Analysis of drug safety profiles for common asthma and allergy medications.
• Examination of risks associated with untreated asthma versus medication side effects.

Main Results:

• Inhaled glucocorticosteroids are recommended for stabilizing asthma during pregnancy.
• Untreated asthma poses a higher risk to both mother and fetus than potential drug side effects.
• Specific antihistamines, dexchlorpheniramine and cetirizine, are identified as suitable options for different trimesters.

Conclusions:

• Asthma management in pregnant women is crucial and should prioritize stabilization with inhaled glucocorticosteroids.
• The benefits of treating maternal asthma generally outweigh the risks of medication side effects.
• Dexchlorpheniramine and cetirizine offer safe antihistamine choices for pregnant individuals, with trimester-specific recommendations.